How much funding has AvantGuard raised?

AvantGuard has raised $2.9M in total funding, most recently a Seed round.

Who are AvantGuard's investors?

AvantGuard's investors include Blue Ledge Capital, SOSV, Launch Ny, Red Bear Angels.

When was AvantGuard founded?

AvantGuard was founded in 2018.

Where is AvantGuard headquartered?

AvantGuard is headquartered in Ithaca, New York, United States.

What industry is AvantGuard in?

AvantGuard operates in Biotech, Healthcare, Chemical Manufacturing.

How many employees does AvantGuard have?

AvantGuard has 11-50 employees.

AvantGuard

Pioneering the future of long-term pathogen protection

Ithaca, United States · Founded 2018 · $2.9M raised

Biotech

Healthcare

Chemical Manufacturing

Headquarters: Ithaca, New York
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: avantguardinc.com
Total Funding: $2.9M
Last Round: $2.9M SeedMay 2023
Rounds: 1

About

AvantGuard (formerly Halomine) is revolutionizing infection control with proprietary N-halamine antimicrobial technology that provides long-term protection against viruses, bacteria, and fungi/mold. Their core product Avantamine extends chlorine's pathogen-killing properties for up to 30 days on surfaces and is applied across healthcare, food processing, and hospitality industries. Founded as a Cornell University spinout, they are focused on combating Candida auris and antimicrobial resistance.

Summary

AvantGuard is a Biotech company based in Ithaca, United States, founded in 2018. It has raised $2.9M in total across 1 round, most recently a $2.9M Seed round in May 2023. Investors include Blue Ledge Capital, SOSV and Launch Ny.